DermOQ and Skin Products, Inc. sign Letter of Intent for Skin Product’s ECHO2 Plus® oxygen facial treatment product line
LOS ANGELES, Oct. 20, 2020 /PRNewswire/ — DermOQ Inc., a leading skin care provider of proprietary topical skin care products delivering molecular oxygen and other active nutrients to the skin and Skin Products, Inc. announced today that they have signed a letter of intent for DermOQ to purchase the ECHO2 Plus® and Oxyceuticals™ oxygen facial treatment product lines.
